NR4A1 and breast carcinoma: Hormone receptor-negative dMMR breast cancer treated with chemotherapy could demonstrate a better prognosis [71, 72], while Hormone receptor-positive breast cancer with dMMR status tend to possess poor outcomes in comparison of Hormone receptor-positive breast cancer with MMR sufficiency [73].